Skip to main content

HHL.TO

ETF
—
—

Performance overview

HHL.TO Price
Price Chart

Forward-looking statistics

Beta
0.65
Risk
13.31%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodActively Managed
DiversifiedNo
Expense ratio0.75%
Asset classUnknown

Top holdings

Boston Scientific Corp5.37%
Eli Lilly and Co5.34%
Medtronic PLC5.30%
Stryker Corp5.22%
Abbott Laboratories5.14%
Zoetis Inc Class A5.11%
Bristol-Myers Squibb Co5.04%
Novartis AG ADR4.90%
Thermo Fisher Scientific Inc4.84%
Other53.75%

Sector exposure

Healthcare100.00%
Other0.00%

Country exposure

United States90.09%
Switzerland5.07%
UK4.85%
Other0.00%

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeToronto Stock Exchange
Type of shareN/A
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)—
Avg trading volume (10 day)—
Put-call ratioN/A

Macro factor sensitivity

Growth+0.2
Credit+2.0
Liquidity-0.1
Inflation-1.9
Commodities-0.1
Interest Rates-0.9

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend day—

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free